Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs) EQUITY
$75.54
neg -0.14
-0.18%
Today's Range: 75.07 - 75.75 | BMY Avg Daily Volume: 5,948,400
Last Update: 07/25/16 - 3:59 PM EDT
Volume: 2,486,875
YTD Performance: 10.02%
Open: $75.73
Previous Close: $75.68
52 Week Range: $51.82 - $77.12
Oustanding Shares: 1,669,307,273
Market Cap: 126,032,699,112
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 6
Moderate Buy 1 1 1 1
Hold 7 7 6 6
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
Mean Rec. 2.32 2.32 2.28 2.37
Latest Dividend: 0.38
Latest Dividend Yield: 2.01%
Dividend Ex-Date: 06/29/16
Price Earnings Ratio: 37.56
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
37.56 81.20 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.07% 9.10% 68.18%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.30 -0.10 -0.02
Net Income -19.60 -0.30 -0.13
EPS -22.50 -0.20 -0.07
Earnings for BMY:
EBITDA 2.27B
Revenue 16.56B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.67 $0.64 $2.63 $3.31
Number of Analysts 10 6 12 12
High Estimate $0.70 $0.68 $2.70 $3.70
Low Estimate $0.64 $0.61 $2.53 $2.79
Prior Year $0.53 $0.39 $2.01 $2.63
Growth Rate (Year over Year) 26.60% 64.10% 30.64% 25.90%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jul 18, 2016 | 6:00 AM EDT
Let me give you the unassailable themes.
By

Jim Cramer

 | Jul 8, 2016 | 3:48 PM EDT

Brexit wasn't the cataclysmic event many pundits wailed about, and while there is still uncertainty, the market is showing its resilience.

By

Doug Kass

 | Jul 7, 2016 | 8:33 AM EDT
The more dire the creditworthiness, the more central banks are buying up a country's sovereign debt. Sovereign credit downgrades are multiply
By

Jim Cramer

 | Jun 28, 2016 | 9:45 AM EDT

One side lied, one side barely tried, the people voted for economic suicide, but it will not stick.  

By

Jim Cramer

 | Jun 22, 2016 | 10:47 AM EDT

This debate is not about EU control of Britain.

By

Bret Jensen

 | Jun 20, 2016 | 12:00 PM EDT

Large biotech stocks are still at their cheapest valuations since 2011.

By

Jim Cramer

 | Jun 15, 2016 | 6:24 AM EDT

This is the group that is the most dangerous politically.

By

Jim Cramer

 | Jun 10, 2016 | 10:36 AM EDT

And the usual suspects need to bottom or keep gaining.

By

Gary Morrow

 | Jun 6, 2016 | 3:17 PM EDT

The stock is gaining today with the help of a nice jump in volume.

By

Jim Cramer

 | Jun 3, 2016 | 11:17 AM EDT
Federal Reserve Chair Janet Yellen should say the Fed can't raise interest rates right now when she speaks in Philadelphia on Monday, according to Jim Cramer.
we are out of AAPL here as this one looks suspect.

we'll cut this one here as the...
Occidental is trading at new July lows this morning.  The stock is off just shy of 1....

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.